232 related articles for article (PubMed ID: 21866546)
1. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
Libreros S; Garcia-Areas R; Shibata Y; Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Cancer; 2012 Jul; 131(2):377-86. PubMed ID: 21866546
[TBL] [Abstract][Full Text] [Related]
2. Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice.
Libreros S; Garcia-Areas R; Keating P; Carrio R; Iragavarapu-Charyulu VL
Front Physiol; 2013; 4():392. PubMed ID: 24399973
[TBL] [Abstract][Full Text] [Related]
3. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J
Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic
Breyne K; Steenbrugge J; Demeyere K; Lee CG; Elias JA; Petzl W; Smith DGE; Germon P; Meyer E
Front Immunol; 2018; 9():1143. PubMed ID: 29892291
[TBL] [Abstract][Full Text] [Related]
5. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
[TBL] [Abstract][Full Text] [Related]
6. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
Chen Y; Zhang S; Wang Q; Zhang X
J Hematol Oncol; 2017 Feb; 10(1):36. PubMed ID: 28143526
[TBL] [Abstract][Full Text] [Related]
7. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
[No Abstract] [Full Text] [Related]
8. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
9. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
Ma B; Herzog EL; Lee CG; Peng X; Lee CM; Chen X; Rockwell S; Koo JS; Kluger H; Herbst RS; Sznol M; Elias JA
Cancer Res; 2015 Feb; 75(3):487-96. PubMed ID: 25511377
[TBL] [Abstract][Full Text] [Related]
10. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
Ma B; Akosman B; Kamle S; Lee CM; He CH; Koo JS; Lee CG; Elias JA
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720089
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
12. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics.
Coffman FD
Crit Rev Clin Lab Sci; 2008; 45(6):531-62. PubMed ID: 19003601
[TBL] [Abstract][Full Text] [Related]
13. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Hembruff SL; Jokar I; Yang L; Cheng N
Neoplasia; 2010 May; 12(5):425-33. PubMed ID: 20454514
[TBL] [Abstract][Full Text] [Related]
14. MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.
Grosso JF; Herbert LM; Owen JL; Lopez DM
J Immunol; 2004 Aug; 173(3):1721-30. PubMed ID: 15265901
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor-derived CCL2 on T cell effector function.
Vitiello PF; Shainheit MG; Allison EM; Adler EP; Kurt RA
Immunol Lett; 2004 Feb; 91(2-3):239-45. PubMed ID: 15019295
[TBL] [Abstract][Full Text] [Related]
16. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
17. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
Lee YS; Yu JE; Kim KC; Lee DH; Son DJ; Lee HP; Jung JK; Kim ND; Ham YW; Yun J; Han SB; Hong JT
Mol Oncol; 2022 Jan; 16(2):508-526. PubMed ID: 34758182
[TBL] [Abstract][Full Text] [Related]
18. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein.
Kawada M; Chen CC; Arihiro A; Nagatani K; Watanabe T; Mizoguchi E
Lab Invest; 2008 Aug; 88(8):883-95. PubMed ID: 18490894
[TBL] [Abstract][Full Text] [Related]
19. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
[TBL] [Abstract][Full Text] [Related]
20. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
